Filing Flows › Outset Medical (OM) › Who owns the stock
Who owns Outset Medical (OM) stock
80 funds reported Outset Medical (OM) shares in their latest 13F filings, worth $61.1M in all. The largest holder is FMR LLC ($11.8M). Last quarter 45 funds added to their stakes and 43 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| FMR LLC | 2,742,887 | $11.8M | increase | 2026-06-30 |
| BML Capital Management, LLC | 2,519,701 | $10.9M | increase | 2026-06-30 |
| AQR Capital Management LLC | 998,961 | $4.3M | increase | 2026-06-30 |
| Vanguard Group | 977,969 | $3.6M | decrease | 2025-12-31 |
| Perceptive Advisors LLC | 833,333 | $3.6M | unchanged | 2026-06-30 |
| Vanguard Capital Management LLC | 780,134 | $3.4M | increase | 2026-06-30 |
| Bank of America | 665,847 | $2.9M | decrease | 2026-06-30 |
| PFM Health Sciences, LP | 582,122 | $2.5M | decrease | 2026-06-30 |
| Ensign Peak Advisors | 434,341 | $1.9M | decrease | 2026-06-30 |
| BlackRock | 418,211 | $1.8M | decrease | 2026-06-30 |
| Assenagon Asset Management S.A. | 339,438 | $1.0M | decrease | 2026-09-30 |
| Peapod Lane Capital LLC | 337,090 | $1.0M | increase | 2026-09-30 |
| Marshall Wace, LLP | 211,993 | $916K | new | 2026-06-30 |
| Geode Capital Management, LLC | 204,652 | $885K | decrease | 2026-06-30 |
| Stratos Wealth Partners | 200,546 | $866K | unchanged | 2026-06-30 |
Outset Medical's latest quarter
Outset Medical, Q3 2026: revenue $33.6M (+14% year over year), operating margin -36.5%, net loss $14.7M, operating cash flow −$10.4M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most OM stock?
By the latest 13F filings: FMR LLC ($11.8M); BML Capital Management, LLC ($10.9M); AQR Capital Management LLC ($4.3M); Vanguard Group ($3.6M); Perceptive Advisors LLC ($3.6M).
What is the short interest in OM?
932,559 shares were sold short at the 2026-10-15 settlement, 17.64% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.